288 filings
Page 2 of 15
8-K
evwri vll2oh1h
23 Jun 23
Submission of Matters to a Vote of Security Holders
4:15pm
8-K
eri1l0
4 May 23
Intra-cellular Therapies Reports First Quarter 2023 Financial Results and Provides Corporate Update
7:37am
ARS
9n2diwvlp9l
28 Apr 23
Annual report to shareholders
5:09pm
DEFA14A
ko2l tpdj
28 Apr 23
Additional proxy soliciting materials
4:42pm
8-K
twty g98n1vfecpc
28 Mar 23
Other Events
7:12am
8-K
8ooj79d
1 Mar 23
Intra-cellular Therapies Reports Fourth Quarter and Full-year 2022 Financial Results and Provides Corporate Update
7:41am
8-K
xftricp0jcxaf98
9 Jan 23
Entry into a Material Definitive Agreement
5:13pm
8-K
hg4 wwwwc3
22 Dec 22
Entry into a Material Definitive Agreement
4:09pm
8-K
2s9 x7pircir637
3 Nov 22
Intra-cellular Therapies Reports Third Quarter 2022 Financial Results and Provides Corporate Update
7:35am
8-K
j1m35y44n
9 Aug 22
Intra-cellular Therapies Reports Second Quarter 2022 Financial Results and Provides Corporate Update
7:38am
8-K
wbq7jvp0
13 Jun 22
Submission of Matters to a Vote of Security Holders
5:01pm
8-K
b074lg jfg8a9
10 May 22
Intra-cellular Therapies Reports First Quarter 2022 Financial Results and Provides Corporate Update
7:37am
8-K
w1wptxknkqxt05q13
25 Apr 22
Intra-Cellular Therapies Announces FDA Approval of New Dosage Strengths for CAPLYTA® (lumateperone) for Specific Patient Populations
7:12am
DEFA14A
wbh cayol
21 Apr 22
Additional proxy soliciting materials
5:04pm